Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: A randomized controlled study.

person Pengfei Yu Department of Abdominal Surgery, Zhejiang Cancer Hospital, Hangzhou, China info_outline Pengfei Yu, Yian Du, Zhiyuan Xu, Ling Huang, Xiangdong Cheng

Authors person Pengfei Yu Department of Abdominal Surgery, Zhejiang Cancer Hospital, Hangzhou, China info_outline Pengfei Yu, Yian Du, Zhiyuan Xu, Ling Huang, Xiangdong Cheng Organizations Department of Abdominal Surgery, Zhejiang Cancer Hospital, Hangzhou, China, Department of abdominal surgery, Zhejiang Cancer Hospital, Hangzhou, China, Department of Gastrointestinal surgery, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China, Department of Abdominal Surgery of Zhejiang Cancer Hospital, Hangzhou,, China Abstract Disclosures Research Funding Other Foundation Background: The optimal extent of lymph node (LN) dissection for advanced distal gastric cancer remains controversial. The present study compared the safety and efficacy of extended LN dissection (D2 plus) with standard D2 radical surgery for advanced distal gastric cancer. Methods: Eligible patients were enrolled and randomly assigned into two groups: D2 group and D2 plus group. Patients in the D2 group received standard D2 LN dissection, while patients in the D2 plus group received an additional no. 8p, 12b, 13 and 14v LNs dissection. The clinicopathological and surgical data of these two groups was compared and the factors that may influence survival were analyzed. Results: 70 patients were enrolled, out of which 64 patients were analyzed. There were no significant differences in the operative time, blood loss and complications between the two groups. In the D2 plus group, the positive rate of the no. 12b, 13 and 14v LN was 3.1%, 9.4% and 12.5%, respectively. The positive rate of the no. 13 LN correlated with the duodenal involvement, while the positive rate of the no. 14v LN correlated with no. 6 LN metastasis. The survival analysis indicated that among patients with duodenum involvement, the 3-year disease free survival rate of the D2 plus group was significantly better than that of the D2 group. Conclusions: Duodenum involvement and positive no. 6 LN were high risk factors of advanced distal gastric cancer. D2 plus radical surgery turned out to be safe and feasible, and may improve the prognosis of these patients. However, further clinical trials are still warranted. Clinical trial information: #NCT01836991.